New drug classes for the treatment of partial onset epilepsy: focus on perampanel

References

• FrenchJAKannerAMBautistaJEfficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyNeurology20046281261127315111660
   PubMed Web of Science ®Google Scholar
• GlauserTBen-MenachemEBourgeoisBUpdated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromesEpilepsia201354355156323350722
   PubMed Web of Science ®Google Scholar
• PeruccaEFrenchJBialerMDevelopment of new antiepileptic drugs: challenges, incentives, and recent advancesLancet Neurol20076979380417706563
   PubMed Web of Science ®Google Scholar
• FrenchJAFaughtERational polytherapyEpilepsia200950Suppl 8636819702736
   PubMed Web of Science ®Google Scholar
• BialerMJohannessenSILevyRHPeruccaETomsonTWhiteHSProgress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)Epilepsy Res2013103123023219031
   PubMed Web of Science ®Google Scholar
• BeyreutherBKFreitagJHeersCKrebsfangerNScharfeneckerUStohrTLacosamide: a review of preclinical propertiesCNS Drug Rev2007131214217461888
   PubMedGoogle Scholar
• BialerMJohannessenSILevyRHPeruccaETomsonTWhiteHSProgress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X)Epilepsy Res2010922–38912420970964
   PubMed Web of Science ®Google Scholar
• RogawskiMARevisiting AMPA receptors as an antiepileptic drug targetEpilepsy Curr2011112566321686307
   PubMed Web of Science ®Google Scholar
• LoscherWSchmidtDEpilepsy: perampanel-new promise for refractory epilepsy?Nat Rev Neurol201281266166223147851
   PubMed Web of Science ®Google Scholar
• KraussGLSerratosaJMVillanuevaVRandomized phase III study 306: adjunctive perampanel for refractory partial-onset seizuresNeurology201278181408141522517103
   PubMed Web of Science ®Google Scholar
• FrenchJAKraussGLBitonVAdjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304Neurology201279658959622843280
   PubMed Web of Science ®Google Scholar
• FrenchJAKraussGLSteinhoffBJEvaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305Epilepsia201354111712522905857
   PubMed Web of Science ®Google Scholar
• HanadaTHashizumeYTokuharaNPerampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsyEpilepsia20115271331134021635236
   PubMed Web of Science ®Google Scholar
• CeolinLBortolottoZABannisterNCollingridgeGLLodgeDVolianskisAA novel anti-epileptic agent, perampanel, selectively inhibits AMPA receptor-mediated synaptic transmission in the hippocampusNeurochem Int201261451752222433907
   PubMed Web of Science ®Google Scholar
• DutySTargeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson’s diseaseCNS Drugs201226121017103223114872
   PubMed Web of Science ®Google Scholar
• KraussGLBarMBitonVTolerability and safety of perampanel: two randomized dose-escalation studiesActa Neurol Scand2012125181521883097
   PubMed Web of Science ®Google Scholar
• RektorIKraussGLBarMPerampanel Study 207: long-term open-label evaluation in patients with epilepsyActa Neurol Scand2012126426326922913800
   PubMed Web of Science ®Google Scholar
• FrancoVCremaFIudiceAZaccaraGGrilloENovel treatment options for epilepsy: focus on perampanelPharmacol Res2013701354023287426
   PubMed Web of Science ®Google Scholar
• KraussGLPeruccaEBen-MenachemEPerampanel, a selective, noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307Epilepsia201354112613422905878
   PubMed Web of Science ®Google Scholar
• LaurenzaAFerryJHusseinZPopulation pharmacokinetics and pharmacodynamics of perampanel: a pooled analysis from three Phase III trialsProceedings of the American Epilepsy Society 65th Annual MeetingDecember 2–6, 2011Baltimore, MD, USA. West Hartford, CT, USA: American Epilepsy Society, 2011
   Google Scholar
• GaoLXiaLZhaoFLLiSCClinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: a meta-analysis of randomized placebo-controlled trialsEpilepsy Res20131031314422776828
   PubMed Web of Science ®Google Scholar
• RogawskiMAHanadaTPreclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonistActa Neurol Scand Suppl2013127Suppl 197192423480152
   PubMedGoogle Scholar
• CramerJAMattsonRHPreveyMLScheyerRDOuelletteVLHow often is medication taken as prescribed? A novel assessment techniqueJAMA198926122327332772716163
   PubMed Web of Science ®Google Scholar
• KwanPBrodieMJEarly identification of refractory epilepsyN Engl J Med2000342531431910660394
   PubMed Web of Science ®Google Scholar
• SimonatoMLoscherWColeAJFinding a better drug for epilepsy: preclinical screening strategies and experimental trial designEpilepsia201253111860186722708847
   PubMed Web of Science ®Google Scholar
• KobowKAuvinSJensenFFinding a better drug for epilepsy: antiepileptogenesis targetsEpilepsia201253111868187623061663
   PubMed Web of Science ®Google Scholar
• LoebJAIdentifying targets for preventing epilepsy using systems biologyNeurosci Lett2011497320521221382442
   PubMed Web of Science ®Google Scholar
• LoscherWSchmidtDModern antiepileptic drug development has failed to deliver: ways out of the current dilemmaEpilepsia201152465767821426333
   PubMed Web of Science ®Google Scholar
• SanchezRMDaiWLevadaRELippmanJJJensenFEAMPA/kainate receptor-mediated downregulation of GABAergic synaptic transmission by calcineurin after seizures in the developing rat brainJ Neurosci200525133442345115800199
   PubMed Web of Science ®Google Scholar
• RakhadeSNZhouCAujlaPKFishmanRSucherNJJensenFEEarly alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizuresJ Neurosci200828327979799018685023
   PubMed Web of Science ®Google Scholar
• BakkerJBasedowFJDekkerADPapantoniouCPhosphorylation of AMPA-type glutamate receptors: the trigger of epileptogenesis?J Neurosci201333145879588023554469
   PubMed Web of Science ®Google Scholar
• JoEKShinDMChoiAMAutophagy: cellular defense to excessive inflammationMicrobes Infect201214211912521924374
   PubMed Web of Science ®Google Scholar
• ShehataMMatsumuraHOkubo-SuzukiROhkawaNInokuchiKNeuronal stimulation induces autophagy in hippocampal neurons that is involved in AMPA receptor degradation after chemical long-term depressionJ Neurosci20123230104131042222836274
   PubMed Web of Science ®Google Scholar
• McMahonJHuangXYangJImpaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesisJ Neurosci20123245157041571423136410
   PubMed Web of Science ®Google Scholar